Bank Of America Corp Catalyst Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

$1.21 Trillion
Q1 2025

A detailed history of Bank Of America Corp transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 1,811,475 shares of CPRX stock, worth $44.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,811,475

Previous 1,568,791 15.47%

Holding current value

$44.5 Million

Previous $32.7 Million 34.17%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$19.53 - $25.74 $4.74 Million - $6.25 Million	242,684 Added 15.47%	1,811,475 $43.9 Million
Q4 2024 Feb 14, 2025	BUY	$19.73 - $23.93 $18 Million - $21.9 Million	913,843 Added 139.53%	1,568,791 $32.7 Million
Q3 2024 Nov 14, 2024	BUY	$15.19 - $21.35 $2.96 Million - $4.17 Million	195,183 Added 42.45%	654,948 $13 Million
Q2 2024 Aug 14, 2024	BUY	$14.68 - $16.92 $756,886 - $872,378	51,559 Added 12.63%	459,765 $7.12 Million
Q1 2024 May 15, 2024	SELL	$13.18 - $17.11 $4.49 Million - $5.83 Million	-340,802 Reduced 45.5%	408,206 $6.51 Million
Q4 2023 Feb 14, 2024	BUY	$11.78 - $17.29 $1.02 Million - $1.5 Million	87,004 Added 13.14%	749,008 $12.6 Million
Q2 2023 Aug 14, 2023	SELL	$11.5 - $18.08 $3.72 Million - $5.86 Million	-323,876 Reduced 32.85%	662,004 $8.9 Million
Q1 2023 May 12, 2023	BUY	$14.34 - $21.05 $995,683 - $1.46 Million	69,434 Added 7.58%	985,880 $16.3 Million
Q4 2022 Feb 10, 2023	BUY	$12.25 - $19.5 $5.39 Million - $8.58 Million	440,187 Added 92.43%	916,446 $17 Million
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $2.51 Million - $5.53 Million	356,077 Added 296.28%	476,259 $6.11 Million
Q2 2022 Aug 12, 2022	SELL	$6.23 - $8.57 $829,487 - $1.14 Million	-133,144 Reduced 52.56%	120,182 $842,000
Q1 2022 May 16, 2022	SELL	$5.31 - $8.31 $491,392 - $769,015	-92,541 Reduced 26.76%	253,326 $2.1 Million
Q4 2021 Feb 08, 2022	BUY	$5.21 - $7.45 $1.14 Million - $1.63 Million	219,197 Added 173.05%	345,867 $2.34 Million
Q3 2021 Nov 15, 2021	SELL	$4.85 - $6.04 $276,847 - $344,775	-57,082 Reduced 31.06%	126,670 $672,000
Q2 2021 Sep 13, 2021	BUY	$4.29 - $6.05 $788,296 - $1.11 Million	183,752 New	183,752 $1.06 Million

Others Institutions Holding CPRX

# of Institutions

388

Shares Held

99.3M

Call Options Held

37K

Put Options Held

20.5K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.52B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Catalyst Pharmaceuticals, Inc. Transaction History